Sale of 587 shares at $200 per share.
Reporting Person Mancini Anthony · Officer Title See Remarks · Transaction Code S
Traded Sep 24, 2026 · Disclosed Sep 28, 2026
Source: SEC Form 4 · 0002124509-26-000012 · filed 2026-09-28 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Revolution Medicines, Inc. (RVMD)." Disclosed 2026-09-28. https://desqlong.com/cards/0002124509-26-000012-1 (retrieved 2026-09-29).